Mycobacterium tuberculosis protein Rv2220 induces maturation and activation of dendritic cells.

Cell Immunol

Department of Microbiology, and Department of Medical Science, College of Medicine, Chungnam National University, Daejeon, South Korea. Electronic address:

Published: June 2018

Tuberculosis remains a serious health problem worldwide. Characterization of the dendritic cell (DC)-activating mycobacterial proteins has driven the development of effective TB vaccine candidates besides improving the understanding of immune responses. Some studies have emphasized the essential role of protein Rv2220 from M. tuberculosis in mycobacterial growth. Nonetheless, little is known about cellular immune responses to Rv2220. In this study, our aim was to test whether protein Rv2220 induces maturation and activation of DCs. Rv2220-activated DCs appeared to be in a mature state with elevated expression of relevant surface molecules and proinflammatory cytokines. DC maturation caused by Rv2220 was mediated by MAPK and NF-κB signaling pathways. Specifically, Rv2220-matured DCs induced the expansion of memory CD62LCD44CD4 T cells in the spleen of mycobacteria-infected mice. Our results suggest that Rv2220 regulates host immune responses through maturation of DCs, a finding that points to a new vaccine candidate against tuberculosis.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cellimm.2018.03.012DOI Listing

Publication Analysis

Top Keywords

protein rv2220
12
immune responses
12
rv2220 induces
8
induces maturation
8
maturation activation
8
rv2220
6
mycobacterium tuberculosis
4
tuberculosis protein
4
maturation
4
activation dendritic
4

Similar Publications

Background: Host-directed therapies are a comparatively new and promising method for the treatment of tuberculosis. A variety of host pathways, vaccines and drugs have the potential to provide novel adjunctive therapies for the treatment of tuberculosis. In this connection, we have earlier reported the immunotherapeutic potential of N-formylated N-terminal peptide of glutamine synthetase of Mycobacterim tuberculosis H37Rv (Mir SA and Sharma S, 2014).

View Article and Find Full Text PDF

Mycobacterium tuberculosis protein Rv2220 induces maturation and activation of dendritic cells.

Cell Immunol

June 2018

Department of Microbiology, and Department of Medical Science, College of Medicine, Chungnam National University, Daejeon, South Korea. Electronic address:

Tuberculosis remains a serious health problem worldwide. Characterization of the dendritic cell (DC)-activating mycobacterial proteins has driven the development of effective TB vaccine candidates besides improving the understanding of immune responses. Some studies have emphasized the essential role of protein Rv2220 from M.

View Article and Find Full Text PDF

Background: In recent years, very few effective drugs against Mycobacterium tuberculosis have emerged, which motivates the research with drugs already used in the treatment of tuberculosis. Ethambutol is a bacteriostatic drug that affects cell wall integrity, but the effects of this drug on bacilli are not fully exploited.

Objective: Based on the need to better investigate the complex mechanism of action of ethambutol, our study presented the proteome profile of M.

View Article and Find Full Text PDF

Background: Tuberculosis (TB) in non-human primates (NHPs) is highly contagious, requiring efficient identification of animals infected with Mycobacterium tuberculosis. Tuberculin skin test is usually used but lacks desirable sensitivity/specificity and efficiency.

Methods: We aimed to develop an immunoassay for plasma antibodies against M.

View Article and Find Full Text PDF

Immunogenicity and protective efficacy of novel Mycobacterium tuberculosis antigens.

Vaccine

September 2013

Laboratory of Mycobacterial Diseases and Cellular Immunology, Center for Biologics Evaluation and Research, United States Food and Drug Administration, Bethesda, MD 20892, United States. Electronic address:

With tuberculosis continuing to be a major cause of global morbidity and mortality, a new vaccine is urgently needed. Tuberculosis subunit vaccines have been shown to induce robust immune responses in humans and are a potentially safer alternative to BCG for use in HIV-endemic areas. In this study, we investigated the protective efficacy of 16 different novel Mycobacterium tuberculosis antigens using an aerogenic mouse model of pulmonary tuberculosis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!